Literature DB >> 19271352

LRP-1: a new modulator of cytoskeleton dynamics and adhesive complex turnover in cancer cells.

Stéphane Dedieu1, Benoit Langlois.   

Abstract

The low-density lipoprotein receptor-related protein-1 (LRP-1)is a large scavenger receptor mediating the internalization and catabolism of various biological components from the extracellular matrix. In the past decade, LRP-1 appeared as an attractive receptor for targeting the invasive behavior of cancer cells since this protein is able to reduce the accumulation of extracellular proteinases by endocytosis. However, recent data suggest that LRP-1 could support carcinoma cell invasion depending on the cellular environment. Indeed, in addition to its well-determined role in ligand binding and endocytosis, LRP-1 emerges as a central molecular regulator of cytoskeleton organization and adhesive complex turnover in malignant cells. This commentary reviews the functions played by LRP-1 in cancer-related events and discusses the potential mechanisms whereby LRP-1 is able to control the cellular phenotype of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19271352      PMCID: PMC2634989          DOI: 10.4161/cam.2.2.6374

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  29 in total

1.  Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function betwenn LRP and the PDGF.

Authors:  Elena Loukinova; Sripriya Ranganathan; Sergey Kuznetsov; Natalia Gorlatova; Mary M Migliorini; Dmitri Loukinov; Paula G Ulery; Irina Mikhailenko; Daniel A Lawrence; Dudley K Strickland
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

Review 2.  LRP: a multifunctional scavenger and signaling receptor.

Authors:  J Herz; D K Strickland
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways.

Authors:  B Degryse; S Orlando; M Resnati; S A Rabbani; F Blasi
Journal:  Oncogene       Date:  2001-04-12       Impact factor: 9.867

4.  LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities.

Authors:  Stéphane Dedieu; Benoît Langlois; Jérôme Devy; Brice Sid; Patrick Henriet; Hervé Sartelet; Georges Bellon; Hervé Emonard; Laurent Martiny
Journal:  Mol Cell Biol       Date:  2008-03-03       Impact factor: 4.272

5.  Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.

Authors:  Y Wei; J A Eble; Z Wang; J A Kreidberg; H A Chapman
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

6.  Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae.

Authors:  Philippe Boucher; Pingsheng Liu; Michael Gotthardt; Thomas Hiesberger; Richard G W Anderson; Joachim Herz
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

7.  Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP).

Authors:  Christina Lutz; Johannes Nimpf; Marcel Jenny; Karl Boecklinger; Christiane Enzinger; Gerd Utermann; Gabriele Baier-Bitterlich; Gottfried Baier
Journal:  J Biol Chem       Date:  2002-08-21       Impact factor: 5.157

8.  Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion.

Authors:  D J Webb; D H Nguyen; S L Gonias
Journal:  J Cell Sci       Date:  2000-01       Impact factor: 5.285

9.  Regulation of Rac1 activation by the low density lipoprotein receptor-related protein.

Authors:  Zhong Ma; Keena S Thomas; Donna J Webb; Radim Moravec; Ana Maria Salicioni; Wendy M Mars; Steven L Gonias
Journal:  J Cell Biol       Date:  2002-12-23       Impact factor: 10.539

10.  Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins.

Authors:  Ralf-Peter Czekay; Kathleen Aertgeerts; Scott A Curriden; David J Loskutoff
Journal:  J Cell Biol       Date:  2003-03-03       Impact factor: 10.539

View more
  15 in total

1.  LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion.

Authors:  Gwenn Perrot; Benoit Langlois; Jérôme Devy; Albin Jeanne; Laurie Verzeaux; Sébastien Almagro; Hervé Sartelet; Cathy Hachet; Christophe Schneider; Emilie Sick; Marion David; Michel Khrestchatisky; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  Mol Cell Biol       Date:  2012-06-18       Impact factor: 4.272

2.  Cholesterol homeostasis and cancer: a new perspective on the low-density lipoprotein receptor.

Authors:  Jia Gu; Neng Zhu; Hong-Fang Li; Tan-Jun Zhao; Chan-Juan Zhang; Duan-Fang Liao; Li Qin
Journal:  Cell Oncol (Dordr)       Date:  2022-07-22       Impact factor: 7.051

3.  The P2Y2 receptor mediates uptake of matrix-retained and aggregated low density lipoprotein in primary vascular smooth muscle cells.

Authors:  Tixieanna Dissmore; Cheikh I Seye; Denis M Medeiros; Gary A Weisman; Barry Bradford; Laman Mamedova
Journal:  Atherosclerosis       Date:  2016-07-29       Impact factor: 5.162

4.  LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways.

Authors:  Benoit Langlois; Gwenn Perrot; Christophe Schneider; Patrick Henriet; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

5.  Role of LRP-1 in cancer cell migration in 3-dimensional collagen matrix.

Authors:  Aline Appert-Collin; Amar Bennasroune; Pierre Jeannesson; Christine Terryn; Guy Fuhrmann; Hamid Morjani; Stéphane Dedieu
Journal:  Cell Adh Migr       Date:  2016-07-27       Impact factor: 3.405

6.  Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type.

Authors:  Bernard Krust; Diala El Khoury; Isabelle Nondier; Calaiselvy Soundaramourty; Ara G Hovanessian
Journal:  BMC Cancer       Date:  2011-08-03       Impact factor: 4.430

7.  A role for hemopexin in oligodendrocyte differentiation and myelin formation.

Authors:  Noemi Morello; Federico Tommaso Bianchi; Paola Marmiroli; Elisabetta Tonoli; Virginia Rodriguez Menendez; Lorenzo Silengo; Guido Cavaletti; Alessandro Vercelli; Fiorella Altruda; Emanuela Tolosano
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

Review 8.  The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease.

Authors:  Takahisa Kanekiyo; Guojun Bu
Journal:  Front Aging Neurosci       Date:  2014-05-20       Impact factor: 5.750

Review 9.  New Insights into VacA Intoxication Mediated through Its Cell Surface Receptors.

Authors:  Kinnosuke Yahiro; Toshiya Hirayama; Joel Moss; Masatoshi Noda
Journal:  Toxins (Basel)       Date:  2016-05-13       Impact factor: 4.546

10.  Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe.

Authors:  Jlenia Brunetti; Lorenzo Depau; Chiara Falciani; Mariangela Gentile; Elisabetta Mandarini; Giulia Riolo; Pietro Lupetti; Alessandro Pini; Luisa Bracci
Journal:  Sci Rep       Date:  2016-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.